Commentary
This study comprehensively investigated temporal trends in NAFLD prevalence at the global, regional, and national levels. The study included 21 regions and 195 countries or territories. The authors assessed secular trends in NAFLD risk factors, according to the Global Burden of Disease study.
In summary, NAFLD prevalence is increasing worldwide, and the disease is being diagnosed in all parts of the world. The highest prevalence was observed in North Africa and the Middle East, while the greatest increase was detected in Western Europe and North America.
Previous Post
Management of NAFLD: a review
Next Post
Adult US population: NAFLD prevalence 38%, NASH 14%